Ignite Creation Date:
2024-05-06 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 12:46 PM
Study NCT ID:
NCT03532516
Status:
AVAILABLE
Last Update Posted:
2023-08-01
First Post:
2018-05-09
Brief Title:
Compassionate Use Program With Brivaracetam for the Treatment of Patients With Epilepsy
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Study Overview
Official Title:
Compassionate Use Program With Brivaracetam for the Treatment of Patients With Epilepsy
Status:
AVAILABLE
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This Compassionate Use Program CUP is setup to provide study patients with continuous access to Brivaracetam BRV for the time period between closures of the long-term follow up studies N01125 N01199 N01372 N01379 and N01315 and when BRV is commercially available
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None